Approval Year
Substance Class |
Nucleic Acid
Created
by
admin
on
Edited
Sat Dec 16 13:39:13 GMT 2023
by
admin
on
Sat Dec 16 13:39:13 GMT 2023
|
Nucleic Acid Type | OLIGONUCLEOTIDE |
Nucleic Acid Subtype | ANTI-SENSE |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
DR9CF3915M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
457914
Created by
admin on Sat Dec 16 13:39:13 GMT 2023 , Edited by admin on Sat Dec 16 13:39:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10433
Created by
admin on Sat Dec 16 13:39:13 GMT 2023 , Edited by admin on Sat Dec 16 13:39:13 GMT 2023
|
PRIMARY | |||
|
DR9CF3915M
Created by
admin on Sat Dec 16 13:39:13 GMT 2023 , Edited by admin on Sat Dec 16 13:39:13 GMT 2023
|
PRIMARY | |||
|
CD-183
Created by
admin on Sat Dec 16 13:39:13 GMT 2023 , Edited by admin on Sat Dec 16 13:39:13 GMT 2023
|
PRIMARY | |||
|
121494124
Created by
admin on Sat Dec 16 13:39:13 GMT 2023 , Edited by admin on Sat Dec 16 13:39:13 GMT 2023
|
PRIMARY | |||
|
1698048-23-5
Created by
admin on Sat Dec 16 13:39:13 GMT 2023 , Edited by admin on Sat Dec 16 13:39:13 GMT 2023
|
PRIMARY | |||
|
C169801
Created by
admin on Sat Dec 16 13:39:13 GMT 2023 , Edited by admin on Sat Dec 16 13:39:13 GMT 2023
|
PRIMARY |
Sugar | Site Range | Site Count |
---|---|---|
2'-O-Methoxyethyl ribose | 1_1-1_2;1_15-1_16 | 4 / 16 |
1_3-1_4;1_13-1_14 | 4 / 16 | |
Deoxyribose (DNA) | 1_5-1_12 | 8 / 16 |
Linkage | Site Range | Site Count |
---|---|---|
Phosporothioate | 1_2-1_16 | 15 / 15 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->INHIBITOR OF EXPRESSION |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Structural Modifications
Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
---|---|---|---|---|---|---|
NUCLEOSIDE_SUBSTITUTION | [1_2] [1_15] | SITE_SPECIFIC | 2'-O-(2-METHOXYETHYL)-5-METHYLCYTIDINE | AOQ54IZZ6J | ||
NUCLEOSIDE_SUBSTITUTION | [1_1] | SITE_SPECIFIC | 2'-O-(2-METHOXYETHYL)-5-METHYLURIDINE | 9Q36I4D9VB | ||
NUCLEOSIDE_SUBSTITUTION | [1_3] [1_4] [1_11] [1_12] | SITE_SPECIFIC | 2'-O,4'-C-((1S)-ETHANE-1,1-DIYL).BETA.-D-RIBOSE 5-METHYL CYTIDINE | 7XRE49320R |